Cardiovascular disease and African Americans: Why determination of race is inadequate for research and practice

Journal of the National Medical Association

Volumn 99, Issue 6, 2007, Pages 686-689

  Ferdinand, Keith C ^a,b  

^a Association of Black Cardiologists   (United States)

^b NONE   (United States)

Author keywords

African Americans; Cardiovascular disease

Indexed keywords

AFRICAN AMERICAN; CARDIOVASCULAR DISEASE; EDITORIAL; ENVIRONMENTAL FACTOR; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIOECONOMICS;

AFRICAN AMERICANS; CARDIOVASCULAR DISEASES; HUMANS; OBESITY; RISK ASSESSMENT; RISK FACTORS; SOCIAL CLASS; UNITED STATES;

EID: 34347356611     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Ferdinand KC, Clark LT, Watson KE, et al. Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial. Am J Cardiol. 2006;97(2):229-235.
2. Taylor AL, Ziesche S, Yancy C, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351(20):2049-2057.
3. Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288(19):2421-2431.
4. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.
5. Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163(5):525-551.
6. Baker EH, Ireson NJ, Carney C, et al. Transepithelial sodium absorption is increased in people of African origin. Hypertension. 2001;38(1):76-80.
7. Su YR, Rutkowski MP, Klanke CA, et al. A novel variant of the beta-subunit of the amiloride-sensitive sodium channel in African Americans. J Am Soc Nephrol. 1996;7(12):2543-2549.
8. Turner ST, Schwartz GL, Chapman AB, et al. C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension. 2001;37(2 Part 2):739-743.
9. McNamara DM, Tam SW, Sabolinski ML, et al. Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial. J Am Coll Cardiol. 2006;48(6):1277-1282.
10. Cooper RS, Wolf-Maier K, Luke A, et al. An international comparative study of blood pressure in populations of European vs. African descent. BMC Med. 2005;3:2.
11. Fang J, Madhavan S, Alderman MH. The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. N Engl J Med. 1996;335(21):1545-1551.
12. Murray CJ, Kulkarni SC, Michaud C, et al. Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med. 2006;3(9):e260.
13. Heart Disease and Stroke Statistics - 2006 Update, American Heart Association. Available: www.americanheart.org/downloadable/heart/ 111166711577754HS_StatsInsideText.pdf. Accessed 04/29/07.
14. Schneider RH, Nidich SI, Salerno JW. The Transcendental Meditation program: reducing the risk of heart disease and mortality and improving quality of life in African Americans. Ethn Dis. 2001;11(1):159-160.
15. Schneider RH, Alexander CN, Staggers F, et al. A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year. Am J Hypertens. 2005;18(1):88-98.